During the past decade, Songklanagarind Hospital; Department of Oncology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Songklanagarind Hospital; Department of Oncology" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Songklanagarind Hospital; Department of Oncology" are "Breast Cancer" (4 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Esophageal Cancer" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Songklanagarind Hospital; Department of Oncology" in a lesser frequency.

Most popular intervention types in "Songklanagarind Hospital; Department of Oncology" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Atezolizumab" (5 trials), "Docetaxel" (3 trials), "Pertuzumab" (3 trials) and "Tiragolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Songklanagarind Hospital; Department of Oncology" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Songklanagarind Hospital; Department of Oncology". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Songklanagarind Hospital; Department of Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Songklanagarind Hospital; Department of Oncology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".